[{"AccountsPayableCurrent_0_FY_USD":1096000.0,"EmployeeRelatedLiabilitiesCurrent_0_FY_USD":508000.0,"AllocatedShareBasedCompensationExpense_4_FY_USD":3970000.0,"ShortTermInvestments_0_FY_USD":1999000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_4_FY_USD":61000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_FY_USD":24846000.0,"LongTermNotesPayable_0_FY_USD":4328000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_FY_USD":4400000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4_FY_USD":100000.0,"RepaymentsOfNotesPayable_4_FY_USD":2333000.0,"ProceedsFromStockOptionsExercised_4_FY_USD":87000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_4_FY_USD":-41873000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_FY_USD":-10121000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_FY_USD":3667000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_FY_USD":4000000.0,"EffectiveIncomeTaxRateReconciliationTaxCredits_4_FY_pure":-0.101,"EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_4_FY_pure":0.0,"DepreciationDepletionAndAmortization_4_FY_USD":288000.0,"ValuationAllowanceDeferredTaxAssetChangeInAmount_4_FY_USD":13100000.0,"NotesPayable_0_FY_USD":8304000.0,"ComprehensiveIncomeNetOfTax_4_FY_USD":-41870000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_4_FY_USD":4461000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_FY_USD":880000.0,"OtherAccruedLiabilitiesCurrent_0_FY_USD":121000.0,"IncreaseDecreaseInAccruedLiabilities_4_FY_USD":1084000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_4_FY_USD":87000.0,"OtherAssetsNoncurrent_0_FY_USD":0.0,"NonoperatingIncomeExpense_4_FY_USD":941000.0,"EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_4_FY_pure":-0.313,"OtherLiabilitiesNoncurrent_0_FY_USD":0.0,"RealizedInvestmentGainsLosses_4_FY_USD":0.0,"ImpairmentOfLongLivedAssetsHeldForUse_4_FY_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_0_FY_shares":1394475.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_16_FY_shares":3530773.0,"SaleOfStockNumberOfSharesIssuedInTransaction_4_FY_shares":2557544.0,"RestructuringReserve_0_FY_USD":1515000.0,"RestructuringCharges_4_FY_USD":2034000.0,"RestructuringCharges_1_FY_USD":900000.0,"RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_4_FY_pure":0.5,"RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_4_FY_position":44.0,"ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans_4_FY_USD":110000.0,"PaymentsToAcquireMarketableSecurities_4_FY_USD":32690000.0,"PaymentsOfStockIssuanceCosts_4_FY_USD":77000.0,"PaymentsForRestructuring_4_FY_USD":519000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_4_FY_USD":3000.0,"LongTermDebt_0_FY_USD":7667000.0,"OperatingLeaseCost_4_FY_USD":300000.0,"IncomeTaxExaminationPenaltiesAndInterestExpense_4_FY_USD":0.0,"EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_4_FY_pure":0.004,"DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_0_FY_USD":829000.0,"DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0_FY_USD":1202000.0,"DeferredTaxAssetsTaxCreditCarryforwards_0_FY_USD":10812000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4_FY_USD":-7760000.0,"CashCashEquivalentsAndShortTermInvestments_0_FY_USD":26800000.0,"AvailableForSaleSecuritiesDebtSecurities_0_FY_USD":2000000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_FY_USD":2000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4_FY_USD":3970000.0,"AccruedRentCurrent_0_FY_USD":66000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_4_FY_USD":432000.0,"AccretionExpense_4_FY_USD":340000.0,"NumberOfOperatingSegments_4_FY_segment":1.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_4_FY_USD":110000.0,"InterestAndDebtExpense_4_FY_USD":835000.0,"DeferredTaxAssetsOperatingLossCarryforwards_0_FY_USD":32792000.0,"ProceedsFromIssuanceOfCommonStock_4_FY_USD":2283000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_FY_USD":2786000.0,"PaymentsToAcquirePropertyPlantAndEquipment_4_FY_USD":84000.0,"NetIncomeLoss_4_FY_USD":-41873000.0,"NetIncomeLoss_1_FY_USD":-10118000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-36056000.0,"NetCashProvidedByUsedInInvestingActivities_4_FY_USD":28226000.0,"NetCashProvidedByUsedInFinancingActivities_4_FY_USD":70000.0,"LiabilitiesCurrent_0_FY_USD":10180000.0,"LiabilitiesAndStockholdersEquity_0_FY_USD":30262000.0,"Liabilities_0_FY_USD":14508000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4_FY_USD":-126000.0,"IncreaseDecreaseInAccountsReceivable_4_FY_USD":84000.0,"IncreaseDecreaseInAccountsPayable_4_FY_USD":525000.0,"GeneralAndAdministrativeExpense_4_FY_USD":11646000.0,"GeneralAndAdministrativeExpense_1_FY_USD":2534000.0,"EarningsPerShareBasicAndDiluted_4_FY_USD":-1.34,"EarningsPerShareBasicAndDiluted_1_FY_USD":-0.31,"CommonStockValue_0_FY_USD":349000.0,"CommonStockSharesOutstanding_0_FY_shares":34861876.0,"CommonStockSharesIssued_0_FY_shares":34861876.0,"AssetsCurrent_0_FY_USD":29739000.0,"Assets_0_FY_USD":30262000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4_FY_shares":3544000.0,"AdditionalPaidInCapital_0_FY_USD":183574000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_FY_USD":0.0,"AccountsReceivableNetCurrent_0_FY_USD":108000.0,"PropertyPlantAndEquipmentNet_0_FY_USD":523000.0,"RetainedEarningsAccumulatedDeficit_0_FY_USD":-168169000.0,"StockholdersEquity_0_FY_USD":15754000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_4_FY_shares":31336409.0,"DeferredTaxAssetsGross_0_FY_USD":46240000.0,"OtherNonoperatingIncomeExpense_1_FY_USD":-47000.0,"DebtInstrumentUnamortizedDiscount_0_FY_USD":32000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_FY_shares":1826218.0,"AccruedProfessionalFeesCurrent_0_FY_USD":254000.0,"PropertyPlantAndEquipmentGross_0_FY_USD":3871000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_FY_USD":300000.0,"EffectiveIncomeTaxRateReconciliationOtherAdjustments_4_FY_pure":-0.039,"EffectiveIncomeTaxRateContinuingOperations_4_FY_pure":0.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_FY_USD":3348000.0,"ShareBasedCompensation_4_FY_USD":3970000.0,"ResearchAndDevelopmentExpense_4_FY_USD":34794000.0,"ResearchAndDevelopmentExpense_1_FY_USD":8417000.0,"DeferredTaxAssetsValuationAllowance_0_FY_USD":46240000.0,"PreferredStockSharesOutstanding_0_FY_shares":0.0,"OperatingLossCarryforwards_0_FY_USD":133000000.0,"OperatingIncomeLoss_4_FY_USD":-41979000.0,"OperatingExpenses_4_FY_USD":46440000.0,"NotesPayableCurrent_0_FY_USD":3976000.0,"InterestPaidNet_4_FY_USD":511000.0,"EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_4_FY_pure":0.037,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4_FY_pure":0.21,"DeferredTaxAssetsNet_0_FY_USD":0.0,"DebtInstrumentCarryingAmount_0_FY_USD":7667000.0,"CommonStockSharesAuthorized_0_FY_shares":100000000.0,"CommonStockParOrStatedValuePerShare_0_FY_USD":0.01,"CommitmentsAndContingencies_0_FY_USD":null,"AccruedLiabilitiesCurrent_0_FY_USD":5108000.0,"PreferredStockSharesAuthorized_0_FY_shares":5000000.0,"UnrealizedGainLossOnInvestments_4_FY_USD":3000.0,"Ticker":"VRDN","CIK":"1590750","name":"MIRAGEN THERAPEUTICS, INC.","OfficialName":"Viridian Therapeutics Inc. Common Stock","form":"10-K","period":"20191231","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"445189274.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200313"}]